Pred-455 — [updated]

PRED-455 stands as a testament to the advancements in chemical synthesis and the potential for discovery in the realm of modern chemistry. Its unique properties and wide-ranging applications make it a compound of significant interest. As research progresses, it is likely that PRED-455 will play an increasingly important role in various scientific and industrial endeavors, contributing to breakthroughs and innovations that can benefit society as a whole.

: Vectors derived from the 3D structure of proteins used to predict mutation effects. Biological Activity Parameters PRED-455

PRED-455, also known as Emicerfont, is a synthetic anxiolytic drug that belongs to the class of 5-HT1A receptor agonists. It was developed in the 1980s by the Japanese pharmaceutical company, Shionogi, as a potential treatment for anxiety disorders. Although PRED-455 has shown promising results in preclinical and clinical trials, its development and availability have been limited due to various factors. In this article, we will explore the history, mechanism of action, therapeutic potential, and current status of PRED-455. PRED-455 stands as a testament to the advancements